InvestigatorCIMIT FriendIndustryPatient
search
Medical Device Regulatory Affairs Newsletters

MARCH 2010 ISSUE:

  • FDA, NIH to Improve Evaluation of New Technologies.
  • FDA Moves to Regulate Health Information Technology Software.
  • FDA Formulating Guidance on Companion Diagnostics.

FEBRUARY 2010 ISSUE:

  • FDA, Industry Discuss Challenges to 510(k) Program.
  • Industry Calls for Higher Payments for New Technologies. 
  • FDA Seeks to Reduce Radiation from Imaging. 
  • 510(k) Task Force Convenes Comparative Effectiveness Meeting.
  • Industry Calls for Exemption of Tests from FDA Review.
  • FDA Needs More Funding, Hamburg Says. 
  • Obama’s Budget Would Create National Device Registry.
  • Medical Imaging Easily Reviewed on Handhelds.
  • Lack of Insurance Hinders Colorectal Screening.
  • FDA Will Hold Public Meeting on 510(k) Pathway. 
  • Industry Seeks Streamlined Event Reporting for Combination Products.
  • Workshop on Interoperable Device Systems Raises Difficult Regulatory Pathway Questions.

JANUARY 2010 ISSUE:

  • Shuren Takes the Helm at CDRH, Issues Agenda for 2010
  • FDA Issues Guidance on Heart Valve Clinical Studies
  • Device Firms Struggling with Corrective and Preventive Actions
  • Radiological Devices Review Moves to OIVD
  • FDA Promises Tougher Standards for PMA Trials.
  • Device Industry Questions Applicability of Pilot Sentinel System.
  • Device Firms Mobilize to Provide Aid to Haiti.
  • NIH Spent $40 Million on Comparative Studies of Devices.
  • Industry Pushing FDA for Companion Diagnostics Guidance.
  • Contrast Imaging Guidance Published, Concerns Remain.
  • FDA Inspections to Increase, Tougher Responses Expected.
  • Industry Still Focused on Device Tax as Negotiations Continue.
  • Coalition Urges Use of Technology to Curb Imaging.

DECEMBER 2009 MONTHLY TOPIC:
Requirements for Disclosure of Financial Ties Between Physicians
and the Medical Device Industry Gain Momentum in 2009

DECEMBER 2009 ISSUE:

  • FDA Seeks Feedback on Incorporating New Science. 
  • Infection Surveillance Saves Money, More Data Needed on Rapid Tests. 
  • Researchers Claim Medical Device Studies Not Robust. 
  • FDA Says Not to Rely on Previous Decisions for 510(k) Submissions. 
  • Panel Recommends Randomized, Controlled Trials for Prostate Cancer Devices.
  • New FDA Chief Counsel Appointed. 
  • Device Industry Groups Lobby for Modifications to Device Tax.
  • Firms Give Advice on eMDR Submission.
  • UDI Pilot Test Report Makes Recommendations to FDA.
  • Task Force Publishes Quality System Guidance.
  • Patients Could See Benefits of Comparative Effectiveness Research Soon.
  • CMS to Reimburse for PET, When Used in Clinical Studies.
  • Device Industry Comments on Electronic MDR Rule.
  • Problems Abound with Adverse Event Reporting on ClinicalTrials.gov.
  • Health Reform Will Affect Laboratory Test Reimbursement, Too.

NOVEMBER 2009 MONTHLY TOPIC:
FDA Holds Forum on Advertising and Promotion with Social Media Tools

NOVEMBER 2009 ISSUE:

  • Senate Halves Device Industry Fee in Revised Bill.
  • Risk Communication Committee Issues Recommendations.
  • Digital Mammography 510(k)s May Require Clinical Data.
  • Court Upholds Civil Money Penalty for Failure to Report MDRs. 
  • Transparency Task Force to Address Industry Concerns.
  • Supreme Court Considering Cases Affecting Diagnostic Test Patents. 
  • Task Force Debates Release of Information on Unapproved Products.
  • FDA Publishes Guidance on Emergency Use of H1N1 Diagnostics.
  • Lawsuit Continues Over Patenting of Breast Cancer Genes. 
  • National Registry, UDI System Proposed in Health Reform. 
  • FDA to Close Loophole for Study Investigators. 
  • House Health Reform Bill Reduces Device Tax.

OCTOBER 2009 MONTHLY TOPIC:
New FDA Leadership Focuses on Regulation and Enforcement

OCTOBER 2009 ISSUE:

  • FDA Looking at Clinicaltrials.gov Compliance.
  • Participants in UDI Pilot Concerned About Feasibility.
  • FDA Issues New CAD Guidance.
  • Shuren Seeking to Lead CDRH Permanently.
  • Committee Calls for More Oversight of Genetic Tests. 
  • Compliance Monitoring Likely on the Upswing at FDA. 
  • Industry Group Refuses to Support Reduced Health Reform Fee. 
  • FDA Calls for Postmarket Data on Spinal Devices.
  • OIG to Investigate FDA Consumer Complaint Process.
  • Amendments to Repeal Device Industry Fee Fail.
  • FDA to Take Task Force’s Advice.
  • FDA Adopts Risk Communication Plan.

SEPTEMBER 2009 MONTHLY TOPIC:
Senate Bill Proposes Funding Health Reform In Part by $40 Billion Fee on the Device Industry

SEPTEMBER 2009 ISSUE:

  • FDA Commissions IOM Review of 510(k) Program.
  • Health Reform Bills Address Physician Payments.
  • FDA Issues Good Manufacturing Practices for Combination Products.
  • New Combination Product Rules Expected Soon.
  • New Guidance Issued for AFib Device Trials. 
  • FDA to Hold Public Meeting on Internet Advertising.
  • Health Reform Bill May Charge Device Industry $4 Billion.
  • Industry Lauds Harkin’s Takeover of Committee.
  • Use of Registries Could Ease Post-Approval Study Burden.
  • Comments on Transparency Task Force Abound.
  • Health Technology Could Bolster Economy. 
  • Industry Concerned about Quality Measures and Reimbursement. 

AUGUST 2009 MONTHLY TOPIC:
Public Reporting of Adverse Events in Device Trials Goes into Effect on September 27, 2009,
Under Default Provisions of FDAAA

AUGUST 2009 ISSUE:

  • Industry Asks for Device-Specific Advertising Guidance.
  • FDA to Require More “522” Post-Approval Studies. 
  • FDA Guidance Aims to Increase Third-Party Inspections. 
  • FDA Proposes Electronic Adverse Event Reporting.
  • CMS Questions Quality of Lab-Developed Tests. 
  • Assays, Masks Under Scrutiny as Flu Season Approaches. 
  • FDA Device Center Director Resigns. 
  • Review of Preamendments Data Begins.
  • Industry Asks Supreme Court to Protect Patents for Diagnostics. 
  • Senators Spar on Preemption for Devices. 
  • Warning Letters to Come Faster, Hamburg Says. 
  • Comparative Effectiveness Budget Plans Detailed. 
  • Rapid Diagnostic Tests Could Reduce Hospital Infections. 
  • Experts Urge Caution in Informal Dialogue with FDA. 
  • Editorial Cites Challenges Facing Sentinel System.

JULY 2009 MONTHLY TOPIC:
Congress, GAO, Commissioner Emphasize Stricter Enforcement of Medical Device Regulations

JULY 2009 ISSUE:

  • FDA Promises More Aggressive Regulation of In Vitro Diagnostics.
  • FDA Unable to Determine its Funding Needs. 
  • FDA Advises Device Companies on Corrective Actions. 
  • Health Reform Could Include Device Registry.
  • Massachusetts Code of Conduct Takes Effect. 
  • Device Firms Concerned Health Reform Could Stifle Innovation.
  • Lawsuits Lodged Against Cardiac Device Companies. 
  • Commissioner Seeks to Restructure FDA Front Office.
  • AdvaMed Urges CMS to Reimburse for Devices Aimed at Infection. 
  • 510(k) Modification Policy Under Fire.
  • Device Firms May be More Vulnerable to Lawsuits.
  • Senate Pain Bill May Benefit Device Companies. 

JUNE 2009 MONTHLY TOPIC:
FDA Forms Transparency Task Force

JUNE 2009 ISSUE:

  • IOM Comparative Effectiveness Recommendations Could Impact Devices. 
  • FDA Guidance on Post-Approval Studies Forthcoming. 
  • Device Industry Urges Task Force to Protect Trade Secrets. 
  • Lawmakers Debate Legislative Changes to the 510(k) Process.
  • Panel Recommends Use of Bayesian Statistics to Support Coverage Decisions.
  • FDA, Industry Discuss Challenges to Universal Identifier System.
  • Kennedy’s Bill Concerns Device Industry. 
  • Health Reform Bills Address Comparative Effectiveness. 
  • Whistleblowers Should Air Grievances Internally First, Industry Says.
  • New Leaders Look to FDA’s Ability to Protect Public Health.
  • EU Medical Device Regulatory Overhaul on the Horizon.
  • Device Expenditures Represent Fraction of U.S. Health Spending.

MAY 2009 MONTHLY TOPIC:
FDA Attempts to Guide Industry on Device Advertising

MAY 2009 ISSUE:

  • Obama Memo Seems to Reject Preemption.
  • New FDA Leaders Will Look Into 510(k) Process.
  • Vermont May Institute Device Firm Disclosure Rules.
  • FDA Performs Internal Review of a 510(k) Clearance. 
  • CMS Refuses to Cover CT Colonography. 
  • Office of Health Reform Leaders Appointed.
  • Obama Requests Budget Increase for FDA Device Center.
  • FDA Revising Training Program for Device Reviewers.
  • Hamburg Outlines Goals, Discusses Device Reviews at Confirmation Hearing. 
  • Swine Flu Prompts Rush for Effective Diagnostic Tests.
  • Device Reps Should Have More Access to Doctors, IOM Says.
  • FDA Drafting QSR Guidance for Clinical Labs.
  • FDA’s New Risk Communication Plan Should Involve Industry.

APRIL 2009 MONTHLY TOPIC:
FDA and Industry Push to Reclassify Certain Devices

APRIL 2009 ISSUE:

  • Congress Seeks Review of Device Approval Process. 
  • Warning Letters Likely for Violations of ASR Regulation.
  • Device Firms to Publicly Report Adverse Events.
  • Intended Use Renders Software Medical Device.
  • Sebelius Answers Senators’ Additional Questions.
  • Competitive Bidding Rule for Certain Devices Takes Effect.  
  • Device Groups Seek to Preserve Preemption. 
  • FDA Requests Data on 25 Pre-Amendments Device Types. 
  • UDIs May Influence Reimbursement Policies.
  • FDA Requests International Joint Replacement Data.
  • Whistleblower Letters Released.
  • Consumers Urge Congress to Allow Device Suits.
  • AdvaMed Creates Plan for IVDs and LDTs.

MARCH 2009 MONTHLY TOPIC:
Supreme Court Ruling Drives Legislators to Challenge Preemption for Medical Devices

MARCH 2009 ISSUE:

  • IRBs Standards Raised at Congressional Hearing.
  • Electronic Medical Records as Medical Devices?
  • FDA/Sponsors Investigate Preclinical Testing for Heart Valves.
  • Industry, FDA Staff Optimistic About New Leadership
  • FDA Memo Urges Confidentiality
  • Chief Counsel Review of QSR Warning Letters May Cease
  • Obama Appoints Hamburg FDA Commissioner
  • Reviewers Continue to Clash with FDA Supervisors over 510(k)s
  • CDRH Issues Guidance Regarding PMA Fees
  • AdvaMed Releases Guidelines for DTC Ads
  • Device Industry Not Likely to be Hard-Hit by Obama Budget
  • FDA, NIH to Address Pediatric Devices
  • FDA Funding on the Rise
  • FDA Increasing its Focus on Science
  • Budget Proposes Pre-authorization for Imaging Services

FEBRUARY 2009 MONTHLY TOPIC:
FDA Working to Devise Unique Identifier System for Devices

FEBRUARY 2009 ISSUE:

  • Comparative Effectiveness Research Made Into Law.
  • Industry Awaits Combination Products Regulations and Guidance
  • Sponsors Requesting Add-On Payments Look for FDA Approvals
  • Comparative Effectiveness Research Bill Passes
  • Sunshine Act Revised to Prevent Duplication
  • FDA to Require More Oversight of Suppliers
  • FDA Unique Identifiers Should Address Risky Products First
  • Administration Official Weighs in on Cost-Effectiveness Research
  • Daschle’s Withdrawal May Have Far-Reaching Effects
  • HHS Guidance Leaves Questions Unanswered
  • FDA Device Staff Refute Whistleblowers’ Claims
  • Device Industry Hopes for Senate Version of Stimulus Bill
  • Globalization Act Addresses Oversight of Foreign Device Manufacturers

JANUARY 2009 MONTHLY TOPIC:
Long-Awaited GAO Report Urges Action on Preamendments Devices

JANUARY 2009 ISSUE:

2008 ARCHIVES


Get Involved Support CIMIT's Mission Join Industry Liaison Program Apply for Grant Contact Us

CIMIT does not rate, endorse, recommend or prescribe any products, procedures or services. Subscribe to CIMIT News in RSS


Contact the Webmaster Site Acknowledgements Copyright © 2010 CIMIT. All rights reserved. site map linking policy privacy